Inhibrx Biosciences was reclassified within the Russell family of indices, being dropped from several growth-oriented indices. This includes the Russell 2000 Growth Index, Russell 2500 Growth Index, Russell 3000E Growth Index, Russell Microcap Growth Index, Russell Small Cap Comp Growth Index, and Russell 3000 Growth Index.
Concurrently, the company was added to the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index. This reclassification reflects a shift in how the company's investment characteristics are categorized by the index provider.
This change indicates a potential re-evaluation of Inhibrx's profile by the market, moving from a growth-focused classification to one emphasizing value and defensive attributes. Such reclassifications can influence institutional investment strategies tied to specific index mandates.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.